arrow
A

Adele Busico

Fondazione IRCCS Istituto Nazionale dei Tumori
H指数:25
被引数:2,475

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Refining high-risk EGFR-mutant lung cancer patients: the role of adjusted variant allele frequency in first-line osimertinib therapy.

优化高风险EGFR突变型肺癌患者的治疗:调整后的变异等位基因频率在一线奥希替尼治疗中的作用。

2025-08-310
PRE
Genomic instability and CCNE1 amplification as emerging biomarkers for stratifying high-grade serous ovarian cancer

基因组不稳定性及CCNE1扩增作为分层高级别浆液性卵巢癌的新兴生物标志物

2025-08-070
OA
Clinical evaluation of the role of miRNA 371 in small testicular masses. Results of the S1STeM 371 Trial

miRNA 371在小睾丸肿块中的作用临床评估。S1STeM 371试验结果

2025-06-010
PRE
Sunitinib for the treatment of patients with advanced pheochromocytomas or paragangliomas: The phase 2 non-randomized SUTNET clinical trial
2024-09-010
PRE
Molecular screening with liquid biopsy for anti-EGFR retreatment in metastatic colorectal cancer: preliminary data from the randomized phase 2 PARERE trial
2024-02-094
OAAI
Multistep tumor genetic evolution and changes in immunogenicity trigger immune-mediated disease eradication in stage IV melanoma: lessons from a single case
2024-01-042
OAAI
Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2

二甲双胍联合兰瑞肽治疗晚期胃肠道或肺神经内分泌肿瘤的安全性和抗肿瘤活性: Ib期试验MetNET2

2023-12-140
OAAI
Genomic and transcriptomic analyses of thyroid cancers identify DICER1 somatic mutations in adult follicular-patterned RAS-like tumors

甲状腺癌的基因组和转录组学分析确定成人滤泡模式RAS样肿瘤中的DICER1体细胞突变

2023-10-055
OAAI
Specific dynamic changes of peripheral blood immune profile (PBIP) associate with clinical response to nivolumab (NIVO) in patients (pts) with metastatic renal cell carcinoma (mRCC): The I-RENE trial (meet-URO 8)
2023-10-011
OAAI
A2AR Expression and Immunosuppressive Environment Independent of KRAS and GNAS Mutations in Pseudomyxoma Peritonei

腹膜假性粘液瘤中A2AR的表达和免疫抑制环境与KRAS和GNAS突变无关

2023-07-204
OAAI
Prognostic Factors Across Poorly Differentiated Neuroendocrine Neoplasms: a Pooled Analysis

低分化神经内分泌肿瘤的预后因素: 一项汇总分析

2022-11-237
PRE
Genetic Layout of Melanoma Lesions Is Associated with BRAF/MEK-Targeted Therapy Resistance and Transcriptional Profiles
2022-11-019
PRE
Transcriptomic signature and immune infiltrate in metastatic collecting duct renal cell carcinoma patients treated with first-line cabozantinib: Results of exploratory endpoints from BONSAI trial (Meeturo 2)
2022-09-010
OAAI
Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model
2022-04-083
OAAI
Variant allele frequency in baseline circulating tumour DNA to measure tumour burden and to stratify outcomes in patients with RAS wild-type metastatic colorectal cancer: a translational objective of the Valentino study
2021-11-2219
OA
The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal Cancer
2021-02-0513
OA